Robust specific RBD responses and neutralizing antibodies after ChAdOx1 nCoV-19 and CoronaVac vaccination in SARS-CoV-2– seropositive individuals

BACKGROUND: The pandemic unleashed by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 500 million people worldwide and caused more than 6 million deaths. Cellular and humoral immunity induced by infection or immunization are key factors in controlling the viral bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Edgar Ruz, Taminato, Monica, de Souza Apostolico, Juliana, Gabrielonni, Maria Cristina, Lunardelli, Victoria Alves Santos, Maricato, Juliana Terzi, Andersen, Monica Levy, Tufik, Sergio, Rosa, Daniela Santoro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942448/
https://www.ncbi.nlm.nih.gov/pubmed/36845213
http://dx.doi.org/10.1016/j.jacig.2023.100083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942448/
https://www.ncbi.nlm.nih.gov/pubmed/36845213
http://dx.doi.org/10.1016/j.jacig.2023.100083

Ejemplares similares